SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Hemispherx Biopharma, Inc.
(NYSE Amex Equities : HEB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Loading HEB News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.62%78.761.2%$808.66m
SRPTSarepta Therapeutics, Inc.
6.01%62.6530.9%$457.85m
AMGNAmgen Inc.
-1.12%169.711.1%$455.78m
BIIBBiogen Inc.
-1.29%310.461.0%$427.66m
MDVNMedivation, Inc.
0.05%81.481.9%$415.69m
CELGCelgene Corporation
-1.67%105.610.8%$376.73m
REGNRegeneron Pharmaceuticals, Inc.
-0.20%420.603.2%$312.21m
CPHDCepheid
0.06%52.664.7%$211.16m
ALXNAlexion Pharmaceuticals, Inc.
-1.48%124.122.3%$171.46m
CLVSClovis Oncology, Inc.
-1.74%36.7925.5%$161.49m
ILMNIllumina, Inc.
0.21%180.723.4%$139.07m
VRTXVertex Pharmaceuticals Incorporated
-0.34%88.822.2%$123.45m
BMRNBioMarin Pharmaceutical Inc.
-0.93%96.153.8%$112.41m
INCYIncyte Corporation
4.28%92.882.7%$111.02m
TSROTESARO, Inc.
-3.41%104.3615.9%$108.00m

Company Profile

Hemispherx Biopharma, Inc. is a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and the experimental immunotherapeutic/antiviral Ampligen. Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. Ampligen includes application as a treatment for Chronic Fatigue Syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Philadelphia, PA.